Australia Markets closed

Abbott Laboratories (ABT)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
125.05+1.74 (+1.41%)
At close: 4:02PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Sep 2021)Next qtr. (Dec 2021)Current year (2021)Next year (2022)
No. of analysts20202424
Avg. Estimate0.931.014.434.66
Low estimate0.90.894.354.4
High estimate0.981.14.565
Year ago EPS0.981.453.654.43
Revenue estimateCurrent qtr. (Sep 2021)Next qtr. (Dec 2021)Current year (2021)Next year (2022)
No. of analysts17172424
Avg. Estimate9.44B9.7B39.84B39.27B
Low estimate9.29B9.5B39.47B38.26B
High estimate9.61B9.94B41.15B40B
Year ago sales8.85B10.7B34.61B39.84B
Sales growth (year/est)6.70%-9.30%15.10%-1.40%
Earnings history29/09/202030/12/202030/03/202129/06/2021
Est. EPS0.911.351.271.02
Actual EPS0.981.451.321.17
Difference0.070.10.050.15
Surprise %7.70%7.40%3.90%14.70%
EPS trendCurrent qtr. (Sep 2021)Next qtr. (Dec 2021)Current year (2021)Next year (2022)
Current estimate0.931.014.434.66
7 days ago0.931.014.434.66
30 days ago0.931.014.434.66
60 days ago0.981.044.364.64
90 days ago0.981.054.384.67
EPS revisionsCurrent qtr. (Sep 2021)Next qtr. (Dec 2021)Current year (2021)Next year (2022)
Up last 7 days21N/AN/A
Up last 30 days2221
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/A111
Growth estimatesABTIndustrySector(s)S&P 500
Current qtr.-5.10%N/AN/AN/A
Next qtr.-30.30%N/AN/AN/A
Current year21.40%N/AN/AN/A
Next year5.20%N/AN/AN/A
Next 5 years (per annum)12.53%N/AN/AN/A
Past 5 years (per annum)8.15%N/AN/AN/A